• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多参数磁共振成像表观扩散系数图上无低信号病灶的低风险前列腺癌患者病理升级的预测因素

Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging.

作者信息

Kang Minyong, Song Byeongdo, Lee Injae, Lee Sang Eun, Byun Seok-Soo, Hong Sung Kyu

机构信息

Department of Urology, Seoul National University Hospital, 101, Daehak-ro, Jongno-Gu, Seoul, Republic of Korea.

Department of Urology, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea.

出版信息

World J Urol. 2016 Nov;34(11):1541-1546. doi: 10.1007/s00345-016-1829-z. Epub 2016 Apr 13.

DOI:10.1007/s00345-016-1829-z
PMID:27074937
Abstract

PURPOSE

To examine the clinicopathological features and identify the predictors of pathological upgrading in low-risk prostate cancer (PCa) patients without hypointense lesions on the apparent diffusion coefficient (ADC) map calculated from multiparametric magnetic resonance imaging.

METHODS

We reviewed the medical records of 1905 PCa patients who underwent radical prostatectomy between 2007 and 2015. All ADC images were graded using the five-grade Likert scale; the positive hypointense lesions were graded 4-5. We analyzed 256 patients with low-risk classifications according to D'Amico criteria. Patients were classified into two groups according to the pathologic upgrading in the surgical specimens. The predictive factors for pathologic upgrading were evaluated using a multivariate logistic regression analysis.

RESULTS

In 256 patients with low-risk PCa, the percentage of positive cores [odds ratio (OR) 1.09; 95 % confidence interval (CI) 1.02-1.16], the percentage of cancer in the positive cores (OR 1.07, 95 % CI 1.03-1.12), and the presence of hypointensity on an ADC map (OR 2.28; 95 % CI 1.23-4.22) were independent predictors of pathologic upgrading. Notably, 138 of low-risk patients (53.9 %) had no hypointense lesions on an ADC map. Of these 138 patients, the percentage of positive cores (OR 1.09; 95 % CI 1.01-1.18) and the percentage of cancer in the positive cores (OR 1.06; 95 % CI 1.01-1.12) remained independent predictors of pathologic upgrading.

CONCLUSIONS

In low-risk PCa patients without hypointense lesions on an ADC map, biopsy-related parameters such as the percentage of positive cores and the percentage of cancer in the positive cores were independent predictors of pathological upgrading following radical prostatectomy.

摘要

目的

研究低风险前列腺癌(PCa)患者的临床病理特征,并确定在多参数磁共振成像计算的表观扩散系数(ADC)图上无低信号病变的患者病理升级的预测因素。

方法

我们回顾了2007年至2015年间接受根治性前列腺切除术的1905例PCa患者的病历。所有ADC图像均采用五级李克特量表进行分级;阳性低信号病变分级为4 - 5级。我们根据达米科标准分析了256例低风险分类的患者。根据手术标本中的病理升级情况将患者分为两组。使用多变量逻辑回归分析评估病理升级的预测因素。

结果

在256例低风险PCa患者中,阳性核心的百分比[比值比(OR)1.09;95%置信区间(CI)1.02 - 1.16]、阳性核心中的癌症百分比(OR 1.07,95% CI 1.03 - 1.12)以及ADC图上的低信号存在情况(OR 2.28;95% CI 1.23 - 4.22)是病理升级的独立预测因素。值得注意的是,138例低风险患者(53.9%)在ADC图上没有低信号病变。在这138例患者中,阳性核心的百分比(OR 1.09;9% CI 1.01 - 1.18)和阳性核心中的癌症百分比(OR 1.06;95% CI 1.01 - 1.12)仍然是病理升级的独立预测因素。

结论

在ADC图上无低信号病变的低风险PCa患者中,活检相关参数如阳性核心的百分比和阳性核心中的癌症百分比是根治性前列腺切除术后病理升级的独立预测因素。

相似文献

1
Predictors of pathological upgrading in low-risk prostate cancer patients without hypointense lesions on an apparent diffusion coefficient map of multiparametric magnetic resonance imaging.多参数磁共振成像表观扩散系数图上无低信号病灶的低风险前列腺癌患者病理升级的预测因素
World J Urol. 2016 Nov;34(11):1541-1546. doi: 10.1007/s00345-016-1829-z. Epub 2016 Apr 13.
2
Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.根据 D'Amico 标准,低危患者根治性前列腺切除术后疾病预后不良的预测因素:多参数磁共振成像的作用。
J Urol. 2014 Aug;192(2):402-8. doi: 10.1016/j.juro.2014.02.2568. Epub 2014 Mar 11.
3
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.3T 磁共振直肠内多参数成像预测低、中、高危前列腺癌患者前列腺外侵犯的价值。
J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.
4
Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.扩散加权成像可预测经活检证实的低级别前列腺癌中Gleason评分的升级。
BJU Int. 2017 Jan;119(1):57-66. doi: 10.1111/bju.13436. Epub 2016 Feb 24.
5
Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.通过磁共振成像的T2加权和扩散加权成像、阳性活检核心数量以及Gleason评分对局限性前列腺癌神经血管束受累进行术前预测。
Asian Pac J Cancer Prev. 2011;12(4):909-13.
6
Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.全肿瘤定量表观扩散系数直方图和纹理分析预测中危3+4=7前列腺癌的Gleason评分升级
AJR Am J Roentgenol. 2016 Apr;206(4):775-82. doi: 10.2214/AJR.15.15462. Epub 2016 Feb 2.
7
Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.当代D’Amico低危前列腺癌患者的主要Gleason分级模式升级:对未来生物标志物和成像方式的影响
BJU Int. 2017 May;119(5):692-699. doi: 10.1111/bju.13570. Epub 2016 Aug 5.
8
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
9
Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy.表观扩散系数值是前列腺癌根治术前未被怀疑的侵袭性的有力预测指标。
World J Urol. 2016 Oct;34(10):1389-95. doi: 10.1007/s00345-016-1789-3. Epub 2016 Feb 22.
10
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer.对低风险前列腺癌患者肿瘤进展为高级别疾病风险进行分层的临床因素。
Tumori. 2018 Mar-Apr;104(2):111-115. doi: 10.5301/tj.5000580. Epub 2018 May 8.

引用本文的文献

1
Prediction of Pathological Upgrading at Radical Prostatectomy in Prostate Cancer Eligible for Active Surveillance: A Texture Features and Machine Learning-Based Analysis of Apparent Diffusion Coefficient Maps.对适合主动监测的前列腺癌患者根治性前列腺切除术中病理升级的预测:基于纹理特征和表观扩散系数图的机器学习分析
Front Oncol. 2021 Feb 4;10:604266. doi: 10.3389/fonc.2020.604266. eCollection 2020.
2
A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience.在经活检证实的前列腺癌患者中,多参数磁共振成像结果为阴性并不能保证不存在显著癌症:一项真实临床经验。
Int Urol Nephrol. 2018 Nov;50(11):1989-1997. doi: 10.1007/s11255-018-1986-7. Epub 2018 Sep 18.
3

本文引用的文献

1
Performance of biopsy factors in predicting unfavorable disease in patients eligible for active surveillance according to the PRIAS criteria.根据PRIAS标准,活检因素在预测适合主动监测的患者不良疾病方面的表现。
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):338-42. doi: 10.1038/pcan.2015.26. Epub 2015 Jun 2.
2
Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.磁共振成像对低风险前列腺癌主动监测候选者疾病重新分类的诊断性荟萃分析
Prostate Cancer Prostatic Dis. 2015 Sep;18(3):221-8. doi: 10.1038/pcan.2015.20. Epub 2015 May 19.
3
Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.韩国男性极低危前列腺癌主动监测的更新临床结果:8 年随访。
Investig Clin Urol. 2017 May;58(3):164-170. doi: 10.4111/icu.2017.58.3.164. Epub 2017 Apr 13.
The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance.
3.0T 弥散加权磁共振成像在选择适合主动监测的前列腺癌患者中的作用。
Prostate Int. 2014 Dec;2(4):169-75. doi: 10.12954/PI.14057. Epub 2014 Dec 30.
4
Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.前列腺癌的主动监测:对用于风险分层的临床病理变量和生物标志物的系统评价
Eur Urol. 2015 Apr;67(4):619-26. doi: 10.1016/j.eururo.2014.10.010. Epub 2014 Oct 31.
5
Active surveillance and surgery in localized prostate cancer.局限性前列腺癌的主动监测与手术治疗
Minerva Urol Nefrol. 2014 Sep;66(3):175-87. Epub 2014 May 28.
6
The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer.在考虑对临床低风险前列腺癌进行主动监测的患者中,MRI靶向活检和确诊活检在癌症分期升级选择中的作用。
World J Urol. 2014 Aug;32(4):951-8. doi: 10.1007/s00345-014-1314-5. Epub 2014 May 12.
7
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.用前列腺特异性抗原检测进行前列腺癌筛查:当前证据回顾。
JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085.
8
Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.改善主动监测低危前列腺癌患者选择和监测的新工具:系统评价。
Eur Urol. 2014 Jun;65(6):1023-31. doi: 10.1016/j.eururo.2014.01.027. Epub 2014 Jan 28.
9
Overdiagnosis and overtreatment of prostate cancer.前列腺癌的过度诊断与过度治疗。
Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9.
10
Percentage of cancer involvement in positive cores can predict unfavorable disease in men with low-risk prostate cancer but eligible for the prostate cancer international: active surveillance criteria.阳性穿刺样本中癌症累及的百分比可以预测低风险前列腺癌但符合前列腺癌国际积极监测标准的男性的不良疾病情况。
Urol Oncol. 2014 Apr;32(3):291-6. doi: 10.1016/j.urolonc.2013.07.004. Epub 2013 Nov 1.